Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

DTaP-IPV vaccine receives marketing authorization in Germany

Feb. 11, 1999

Adjuvants and immunoeffectors from AGP series under evaluation at Ribi

Feb. 9, 1999

NIH seeks licensees and/or CRADA partners for development of HCV vaccine

Feb. 9, 1999

Novartis describes new PNP inhibitor series in recent patent literature

Feb. 8, 1999

Novel ferrioxamine immunosuppressant discovered at Japanese research institutes

Feb. 5, 1999

Abgenix reports positive preliminary results from phase II trial of GVHD treatment

Feb. 5, 1999

EMEA marketing approval for Triacelluvax

Feb. 4, 1999

New immunomodulator LK-423 possesses unique pharmacological properties

Feb. 3, 1999

Clinical trials for Japanese immunosuppressant begin in Europe

Feb. 3, 1999

Priority review status assigned to Rapamune immunosuppressive therapy

Feb. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...